Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ANGIOtensin II for Septic Shock in the Emergency Department: ANGIO-ED Study

NCT06693726 is registered in ClinicalTrials.gov with Brett A Faine as lead sponsor.

NCT NCT06693726
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06693726 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ANGIOtensin II for Septic Shock in the Emergency Department: ANGIO-ED Study
Lead sponsor
Brett A Faine
Phase
Phase 4
Overall status
Recruiting
Start date
April 1, 2025
Completion date
January 30, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock